FR2504802A1 - Preparations pharmaceutiques a liberation reglee - Google Patents

Preparations pharmaceutiques a liberation reglee Download PDF

Info

Publication number
FR2504802A1
FR2504802A1 FR8207240A FR8207240A FR2504802A1 FR 2504802 A1 FR2504802 A1 FR 2504802A1 FR 8207240 A FR8207240 A FR 8207240A FR 8207240 A FR8207240 A FR 8207240A FR 2504802 A1 FR2504802 A1 FR 2504802A1
Authority
FR
France
Prior art keywords
vitamin
nitroso
blocking agent
stomach
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8207240A
Other languages
English (en)
French (fr)
Other versions
FR2504802B1 (enExample
Inventor
William Joseph Mergens
Harold Leon Newmark
Prabhakar Ranchhordas Sheth
Jacques Levon Tossounian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2504802A1 publication Critical patent/FR2504802A1/fr
Application granted granted Critical
Publication of FR2504802B1 publication Critical patent/FR2504802B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8207240A 1981-04-29 1982-04-27 Preparations pharmaceutiques a liberation reglee Granted FR2504802A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25896281A 1981-04-29 1981-04-29

Publications (2)

Publication Number Publication Date
FR2504802A1 true FR2504802A1 (fr) 1982-11-05
FR2504802B1 FR2504802B1 (enExample) 1985-05-10

Family

ID=22982879

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8207240A Granted FR2504802A1 (fr) 1981-04-29 1982-04-27 Preparations pharmaceutiques a liberation reglee

Country Status (6)

Country Link
JP (1) JPS57183718A (enExample)
CH (1) CH649215A5 (enExample)
DE (1) DE3215086A1 (enExample)
FR (1) FR2504802A1 (enExample)
GB (1) GB2097676B (enExample)
IT (1) IT1195924B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
NZ553587A (en) 2004-08-13 2010-12-24 Boehringer Ingelheim Int Extended release tablet formulation containing pramipexole or a pharmacutically acceptable salt thereof
EA201001086A1 (ru) 2004-08-13 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244468A1 (en) * 1973-07-31 1975-04-18 Passwater Richard Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
FR2304354A1 (fr) * 1975-03-17 1976-10-15 Hoffmann La Roche Nouvelles compositions pharmaceutiques a activite retardee

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380953A (de) * 1956-11-30 1964-08-15 Hoechst Ag Verfahren zur Herstellung von phosphorhaltigen Polyestern
IL24216A (en) * 1964-09-09 1968-11-27 Hoffmann La Roche Vitamin preparation and process for the manufacture thereof
FR1446273A (fr) * 1964-09-09 1966-07-15 Hoffmann La Roche Procédé pour la fabrication d'une préparation vitaminée
AT257330B (de) * 1964-09-09 1967-10-10 Hoffmann La Roche Verfahren zur Herstellung eines Vitaminpräparates
FR5041M (enExample) * 1965-10-01 1967-05-02
US3607310A (en) * 1966-07-29 1971-09-21 James F Carter Jr Production of fortified sugar
NL7106929A (enExample) * 1970-05-20 1971-11-23
DD103056B1 (de) 1972-01-12 1980-11-26 Kurt Schuch Einrichtung zum messen von verschiebungen
CH584013A5 (enExample) * 1972-12-15 1977-01-31 Hoffmann La Roche
US3950547A (en) * 1974-08-26 1976-04-13 Syntex (U.S.A.) Inc. Dietary composition and methods of preparing
GB2052986B (en) * 1979-07-09 1983-08-17 Graebner E B Reducing smoking urge

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244468A1 (en) * 1973-07-31 1975-04-18 Passwater Richard Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
FR2304354A1 (fr) * 1975-03-17 1976-10-15 Hoffmann La Roche Nouvelles compositions pharmaceutiques a activite retardee

Also Published As

Publication number Publication date
DE3215086A1 (de) 1982-11-18
GB2097676A (en) 1982-11-10
IT1195924B (it) 1988-11-03
IT8220999A0 (it) 1982-04-29
GB2097676B (en) 1985-02-13
JPS57183718A (en) 1982-11-12
CH649215A5 (de) 1985-05-15
FR2504802B1 (enExample) 1985-05-10

Similar Documents

Publication Publication Date Title
MC1101A1 (fr) Composition a activite retardee
BE1005691A4 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation.
BE1015217A5 (enExample)
US5169634A (en) Pharmaceutical dosage form for the medication of fish
CH650674A5 (fr) Poudre a base de sel d'addition d'acide de bacampicilline micro-encapsule et composition pharmaceutique la contenant.
FR2568472A1 (fr) Preparations pharmaceutiques retard et procede pour les fabriquer
FR2618673A1 (fr) Formule medicamenteuse a liberation controlee
BE904899A (fr) Compositions therapeutiques flottantes a degagement progressif.
FR2512676A1 (fr) Composition a liberation commandee hydrodynamiquement equilibree
EA009335B1 (ru) Способ и состав для связывания ацетальдегида в слюне, желудке и толстой кишке
EP1615632B1 (fr) Formulations orales flottantes pour la liberation controlee de la betaine
BE1017903A3 (fr) Compositions pharmaceutiques a activite antibiotique.
EP2651422B1 (fr) Compositions a base d'argile et de beepollen, leur procede de preparation et leurs utilisations en nutrition et en therapeutique
FR2813761A1 (fr) Produit alimentaire d'activation intestinale utilisant de la poudre de natto
EP0983065A1 (fr) Composition pharmaceutique a residence gastrique
FR2509174A1 (fr) Composition anti-acide a base de n-acetyl-p-aminophenol
US4681756A (en) Prevention of N-nitroso compound formation in vivo
FR2913338A1 (fr) Composition de rehydratation.
GB2097676A (en) Pharmaceutical composition for prevention of formation of N-nitroso compounds
BE839604A (fr) Composition a activite retardee
LU508270B1 (fr) Composition à base de craie et ses utilisations
FR2750859A1 (fr) Composition pharmaceutique destinee a une administration par voie buccale avec absorption d'au moins un principe actif a travers les muqueuses de la bouche
FR2493146A1 (fr) Melange de cromoglycate de sodium avec un excipient hydrosoluble et procede pour sa preparation pour traiter les affections du tractus gastro-intestinal
FR2938430A1 (fr) Granules a base de plantes
EP4294383A1 (fr) Composition pour renforcer le systeme immunitaire

Legal Events

Date Code Title Description
ST Notification of lapse